FTC Warns 24 Major Hospital Systems Over Deceptive Pricing Practices

The Federal Trade Commission sent warning letters to 24 of the nation's largest hospital and health-system operators on Monday, telling them that failing to give patients timely, accurate and complete prices for scheduled services could expose them to federal liability even if they technically comply with existing transparency rules. The letters, built from a template the agency published alongside the action, warn that incomplete estimates, omitted facility or physician fees, and delayed disclosures for shoppable procedures may amount to unfair or deceptive practices under Section 5 of the FTC Act.

The agency's move layers a new enforcement threat on top of a federal price-transparency regime that has struggled for compliance since it took effect in 2021. Hospitals are required under rules enforced by the Centers for Medicare & Medicaid Services to post machine-readable price lists and consumer-friendly estimates for common procedures, but CMS's own compliance program has found only roughly half of hospitals fully meeting the standard; the agency sent warning letters to more than 500 hospitals this past summer, and noncompliant facilities can face civil penalties running up to $2 million a year. The FTC's letters make clear that meeting CMS's technical requirements will not, by itself, protect a hospital from a separate deceptive-practices case.

FTC Chairman Andrew Ferguson framed the action as a consumer-protection priority distinct from the CMS rule. "Price transparency is particularly critical in the hospital and healthcare setting because healthcare is often one of the most significant and financially burdensome costs consumers face," he said in the agency's announcement. Health and Human Services Secretary Robert F. Kennedy Jr. echoed the message, saying "Americans should know what their healthcare will cost before they receive it." The letters grow out of a Healthcare Task Force Ferguson launched in March to prioritize investigations into pricing, billing and competition practices across the industry.

The commission did not publicly name the 24 companies that received letters, and no hospital system has yet been sued over pricing disclosures tied to this round of warnings. But the agency has already tested the theory in court this year with a suit against online retailer Lens.com over allegedly misleading price claims, a case regulators have cited as a template for how deceptive-pricing law could reach healthcare providers. Trade press covering the hospital letters noted the FTC's emphasis that patients who cannot see a price in advance cannot comparison shop, while hospitals that do disclose honestly are placed at a competitive disadvantage against those that do not, a dynamic regulators say justifies federal intervention beyond CMS's existing enforcement.

For patients, the practical stakes are immediate: unclear hospital pricing has long been cited as a driver of surprise medical bills and billing disputes, particularly for scheduled, non-emergency care where advance shopping is possible in theory but rarely easy in practice. If the FTC follows through with enforcement, hospitals could face the same kind of deceptive-advertising cases the agency has brought in retail and consumer markets, a shift that health policy analysts say would mark a meaningful escalation beyond the CMS compliance letters hospitals have faced to date.